Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Neelakandan Muthukumaran"'
Autor:
Abhilash K. Ravindranath, Lorna Rodriguez-Rodriguez, Neelakandan Muthukumaran, Karl E. Miletti-González
Publikováno v:
Molecular Cancer Research. 4:511-520
Chronic inflammation is implicated in the pathophysiology of ovarian cancer. Tumor necrosis factor-α (TNF-α), a major inflammatory cytokine, is abundant in the ovarian cancer microenvironment. TNF-α modulates the expression of CD44 in normal T lym
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a12a6c3a6dfab58c9d6ae112afff62e0
https://doi.org/10.1158/1541-7786.mcr-05-0232
https://doi.org/10.1158/1541-7786.mcr-05-0232
Autor:
William N. Hait, Karl E. Miletti-González, Shiling Chen, Lorna Rodriguez-Rodriguez, Jin Ming Yang, Weichung Joe Shih, Kevin Apolito, Neelakandan Muthukumaran, Giuseppa N. Saglimbeni, Xiaohua Wu
Publikováno v:
Cancer research. 65(15)
Invasion and metastases of cancer cells and the development of resistance to anticancer therapies are the main causes of morbidity and mortality from cancer. For more than two decades, these two important but not clearly related aspects in the biolog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::931a44544db93ff01e7b4ebae8c23ca7
https://pubmed.ncbi.nlm.nih.gov/16061646
https://pubmed.ncbi.nlm.nih.gov/16061646
Autor:
Darlene Gibbon, Murugesan Gounder, Mihae Song, Wilberto Nieves-Neira, Mira Hellmann, Lorna Rodriguez-Rodriguez, Susan Goodin, Ami Vaidya, Brian Buckley, Neelakandan Muthukumaran
Publikováno v:
Cancer Research. 74:CT219-CT219
Objective: The development of drug resistance is a major cause of gynecologic cancer deaths. Selenium (Se) inhibits the development of carboplatin (C) drug resistance in a mouse ovarian cancer xenograft model. Based on this data, a Phase I trial of a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bd5cfb678aed8c4ece310104c34a3013
https://doi.org/10.1158/1538-7445.am2014-ct219
https://doi.org/10.1158/1538-7445.am2014-ct219
Autor:
Christine L. Hostetter, Karl E. Miletti-González, Neelakandan Muthukumaran, Judith C. Keen, Abhilash K. Ravindranath, Lorna Rodriguez-Rodriguez
Publikováno v:
Cancer Research. 71:3078-3078
CD44, a major hyaluronic acid (HA) receptor, is involved in cell migration, metastasis and tumor progression. While in normal ovarian epithelium CD44 is not expressed, ovarian carcinoma cells express multiple CD44 isoforms as the tumor progresses and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a3417dec07c50c93285220c340d7a6fe
https://doi.org/10.1158/1538-7445.am2011-3078
https://doi.org/10.1158/1538-7445.am2011-3078